Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of Bronchiectasis and Associated Cardiovascular Comorbidities

NCT: NCT05783869 · RECRUITING

NCT IDNCT05783869
StatusRECRUITING
Start Date2023-03-25
Completion2026-11-02

Brief Summary

Effect of cardiovascular comorbidities on disease severity and quality of life in Patients with acute exacerbation of non-cystic fibrosis bronchiectasis

Frequently Asked Questions

What is Study of Bronchiectasis and Associated Cardiovascular Comorbidities?

Study of Bronchiectasis and Associated Cardiovascular Comorbidities is a clinical trial registered under NCT05783869. Current status: RECRUITING.

What is the status of NCT05783869?

The current status of NCT05783869 (Study of Bronchiectasis and Associated Cardiovascular Comorbidities) is: RECRUITING.

When did Study of Bronchiectasis and Associated Cardiovascular Comorbidities start?

Study of Bronchiectasis and Associated Cardiovascular Comorbidities started on 2023-03-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑